Abstract
Acquisition of resistance to anoikis (detachment-induced apoptosis) is considered to be a requirement for transformed intestinal epithelial cells to invade surrounding tissues and metastasize to distant organs. Increased Src kinase activity, which is a feature of a large proportion of colorectal cancers, has been identified as one of the factors that can contribute to anoikis resistance. However, the molecular mechanism by which high levels of Src activity contribute to anoikis resistance in intestinal epithelial cells is unknown. Here we show that high Src activity confers resistance to anoikis in intestinal epithelial cells, at least in part, by inducing Bcl-xL overexpression, and that this induction is mediated by the MEK/MAPK pathway. Based on the findings reported here, and on our previous study showing that Bcl-xL plays a critical role in ras-induced resistance to anoikis, we propose that the increased Bcl-xL levels found in colorectal cancers play a significant role in the induction of resistance to anoikis during the progression of this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abram CL, Courtneidge SA . 2000 Exp. Cell. Res. 254: 1–13
Barbacid M . 1987 Annu. Rev. Biochem. 56: 779–827
Biscardi JS, Tice DA, Parsons SJ . 1999 Adv. Cancer Res 61–119
Bjorge JD, Jakymiw A, Fujita DJ . 2001 Oncogene 19: 5620–5635
Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B . 1987 Nature 327: 293–297
Bowman T, Garcia R, Turkson J, Jove R . 2000 Oncogene 19: 2474–2488
Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE . 1998 Mol. Cell. Biol. 18: 2553–2558
Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J . 2001 Oncogene 20: 7925–7934
Cartwright CA, Meisler AI, Eckhart W . 1990 Proc. Natl. Acad. Sci. USA 87: 558–562
Daigo Y, Furukawa T, Ishiguro H, Fujita M, Sugai S, Nakamori S, Liefers GJ, Tollenaar RAEM, van de Velde CJH, Nakamura Y . 1999 Cancer Res. 59: 4222–4224
Frisch SM, Francis H . 1994 J. Cell Biol. 124: 619–626
Frisch SM, Ruoslahti E . 1997 Curr. Opin. Cell Biol. 9: 701–706
Frisch SM, Screaton RA . 2001 Curr. Opin. Cell Biol. 13: 555–562
Grossmann J, Maxson JM, Whitacre CM, Orosz DE, Berger NA, Fiocchi C, Levine AD . 1998 Am. J. Pathol. 153: 53–62
Han NM, Curley SA, Gallick GE . 1996 Clin. Cancer Res. 2: 1397–1404
Hjelle B, Liu E, Bishop JM . 1988 Proc. Natl. Acad. Sci. USA 85: 4355–4359
Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ . 1999 Nature Genet. 21: 187–190
Irby RB, Yeatman TJ . 2000 Oncogene 19: 5636–5642
Jamal HH, Cano-Gauci DF, Buick RN, Filmus J . 1994 Oncogene 9: 417–423
Jost M, Hugget TM, Kari C, Boise LH, Rodeck U . 2001 J. Biol. Chem. 276: 6320–6326
Karni R, Jove R, Levitzki A . 1999 Oncogene 18: 4654–4662
Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC . 1996 Cancer Res. 56: 2422–2427
Laghi L, Bianchi P, Orbetegli O, Roncalli M, Malesci A . 2001 Br. J. Cancer 84: 196–198
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG . 1994 Science 265: 966–970
Meredith JE, Fazeli B, Schwartz MA . 1993 Mol. Biol. Cell 4: 953–961
Meredith JE, Schwartz MA . 1997 Trends Cell Biol. 7: 147–150
Nguyen KT, Wang WJ, Chan JLK, Wang LH . 2000 Oncogene 19: 5385–5397
Odajima J, Matsumura I, Sonoyama J, Daino H, Kawasaki A, Tanaka H, Inohara N, Kitamura T, Downward J, Nakajima K, Hirano T, Kanakura Y . 2000 J. Biol. Chem. 275: 24096–24105
Oldham SM, Clark GJ, Gangarosa LM, Coffey RJ, Der CJ . 1996 Proc. Natl. Acad. Sci. USA 93: 6924–6928
Oldham SM, Cox AD, Reynolds ER, Sizemore NS, Coffey RJ, Der CJ . 1998 Oncogene 17: 2565–2573
Penuel E, Martin GS . 1999 Mol. Biol. Cell 10: 1693–1703
Pories SE, Hess DT, Swenson K, Lotz M, Moussa R, Steele G, Shibata D, Rieger-Christ KM, Summerhayes IC . 1998 Gastroenterology 114: 1287–1295
Rak J, Mitsuhashi Y, Erdos V, Huang S-N, Filmus J, Kerbel RS . 1995 J. Cell Biol. 131: 1587–1598
Rosen K, Loza Coll M, Li A, Filmus J . 2001 J. Biol. Chem. 276: 37273–37279
Rosen K, Rak J, Jin J, Kerbel RS, Newman MJ, Filmus J . 1998 Curr. Biol. 8: 1331–1334
Rosen K, Rak J, Leung T, Dean NM, Kerbel RS, Filmus J . 2000 J. Cell Biol. 149: 447–455
Schulze A, Lehmann K, Jefferies HB, McMahon M, Downward J . 2001 Genes Dev. 15: 981–994
Schwartzberg PL . 1998 Oncogene 17: 1463–1468
Staley CA, Parikh NU, Gallick GE . 1997 Cell Growth Differ. 8: 269–274
Strater J, Wedding U, Barth TFE, Koretz K, Elsing C, Moller P . 1996 Gastroenterology 110: 1776–1784
Talamonti MS, Roh MS, Curley SA, Gallick GE . 1993 J. Clin. Invest. 91: 53–60
Acknowledgements
We thank Penny Papadakos for her assistance in the preparation of the manuscript. We also thank Dr Natalie Ahn for the dnMEK plasmid. This work has been supported by the National Cancer Institute of Canada.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coll, M., Rosen, K., Ladeda, V. et al. Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells. Oncogene 21, 2908–2913 (2002). https://doi.org/10.1038/sj.onc.1205388
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205388
Keywords
This article is cited by
-
Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists
Oncogene (2015)
-
Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression
Nature Reviews Cancer (2014)
-
Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis
Journal of Cancer Research and Clinical Oncology (2013)
-
A genome wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance
Apoptosis (2012)
-
Apoptosis and Inflammation: Role of Adipokines in Inflammatory Bowel Disease
Clinical and Translational Gastroenterology (2010)